Header Logo

Connection

Lee Fairlie to Humans

Back to Details
This is a "connection" page, showing publications Lee Fairlie has written about Humans.
Lee Fairlie
Connection Strength
1,926
Humans
  1. Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. J Acquir Immune Defic Syndr. 2024 Oct; 97(2):150-155.
    View in: PubMed
    Score: 0,072
  2. More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2023 12 15; 94(5):412-420.
    View in: PubMed
    Score: 0,068
  3. High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa. Int J Infect Dis. 2022 Dec; 125:241-249.
    View in: PubMed
    Score: 0,063
  4. HIV treatment success in children and adolescents with HIV. Lancet HIV. 2022 08; 9(8):e526-e527.
    View in: PubMed
    Score: 0,062
  5. Combination HIV prevention reduces orphanhood in Uganda. Lancet HIV. 2022 01; 9(1):e5-e6.
    View in: PubMed
    Score: 0,059
  6. Effects of preconception antiretroviral therapy in placenta development and pregnancy outcomes. AIDS. 2021 06 01; 35(7):1139-1141.
    View in: PubMed
    Score: 0,057
  7. COVID-19 in pregnancy in South Africa: Tracking the epidemic and defining the natural history. S Afr Med J. 2020 07 30; 110(8):729-731.
    View in: PubMed
    Score: 0,054
  8. Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards? J Int AIDS Soc. 2019 09; 22(9):e25372.
    View in: PubMed
    Score: 0,050
  9. High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa. Medicine (Baltimore). 2018 Jul; 97(29):e10901.
    View in: PubMed
    Score: 0,047
  10. Lamivudine monotherapy in children and adolescents: The devil is in the detail. S Afr Med J. 2017 Nov 27; 107(12):1055-1057.
    View in: PubMed
    Score: 0,045
  11. CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States. AIDS. 2015 Oct 23; 29(16):2109-19.
    View in: PubMed
    Score: 0,039
  12. Outcomes in treatment with darunavir/ritonavir in ART-experienced paediatric patients. S Afr Med J. 2015 Apr 08; 105(5):330-1.
    View in: PubMed
    Score: 0,037
  13. Providing comprehensive health services for young key populations: needs, barriers and gaps. J Int AIDS Soc. 2015; 18(2 Suppl 1):19833.
    View in: PubMed
    Score: 0,037
  14. Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa. Int J Tuberc Lung Dis. 2014 Jun; 18(6):676-81.
    View in: PubMed
    Score: 0,035
  15. Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents. J Int AIDS Soc. 2013 Jun 18; 16:18579.
    View in: PubMed
    Score: 0,033
  16. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis. 2011 Jan 26; 11:28.
    View in: PubMed
    Score: 0,028
  17. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis. Lancet Child Adolesc Health. 2025 Feb; 9(2):100-111.
    View in: PubMed
    Score: 0,018
  18. Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective. Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S85-S89.
    View in: PubMed
    Score: 0,018
  19. Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial. Hum Vaccin Immunother. 2025 Dec; 21(1):2450120.
    View in: PubMed
    Score: 0,018
  20. Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis. N Engl J Med. 2024 Dec 19; 391(24):2315-2326.
    View in: PubMed
    Score: 0,018
  21. A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis. NEJM Evid. 2025 Jan; 4(1):EVIDoa2400190.
    View in: PubMed
    Score: 0,018
  22. Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2425147.
    View in: PubMed
    Score: 0,018
  23. Burden of Lassa fever disease in pregnant women and children and options for prevention. Vaccine. 2025 Jan 01; 43(Pt 1):126479.
    View in: PubMed
    Score: 0,018
  24. South African Parents' and Grandparents' Perspectives on the Acceptability of Implant Delivery of Treatment to Young Children with HIV. AIDS Behav. 2025 Jan; 29(1):13-21.
    View in: PubMed
    Score: 0,018
  25. Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial. J Acquir Immune Defic Syndr. 2024 Oct 01; 97(2):172-179.
    View in: PubMed
    Score: 0,018
  26. Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial. J Acquir Immune Defic Syndr. 2024 Aug; 96(4):385-392.
    View in: PubMed
    Score: 0,018
  27. Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum. Clin Infect Dis. 2024 Jun 14; 78(6):1617-1628.
    View in: PubMed
    Score: 0,018
  28. Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study. HIV Med. 2024 Jul; 25(7):826-839.
    View in: PubMed
    Score: 0,017
  29. Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial. AIDS. 2024 07 15; 38(9):1304-1313.
    View in: PubMed
    Score: 0,017
  30. Obstetric and neonatal outcomes in South Africa. Vaccine. 2024 Feb 27; 42(6):1352-1362.
    View in: PubMed
    Score: 0,017
  31. Translating the consent form is the tip of the iceberg: using cognitive interviews to assess the barriers to informed consent in South African health facilities. Sex Reprod Health Matters. 2023 Dec; 31(4):2302553.
    View in: PubMed
    Score: 0,017
  32. DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy. J Acquir Immune Defic Syndr. 2024 01 01; 95(1):65-73.
    View in: PubMed
    Score: 0,017
  33. Preferences for onward health data use in the electronic age among maternity patients and providers in South Africa: a qualitative study. Sex Reprod Health Matters. 2023 Dec; 31(4):2274667.
    View in: PubMed
    Score: 0,017
  34. Acceptability of the Dapivirine Vaginal Ring and Oral Truvada Among African Users in Late-Stage of Pregnancy. AIDS Behav. 2024 Mar; 28(3):963-973.
    View in: PubMed
    Score: 0,017
  35. Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents. Clin Pharmacokinet. 2023 10; 62(10):1445-1459.
    View in: PubMed
    Score: 0,017
  36. Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. N Engl J Med. 2023 Jul 20; 389(3):215-227.
    View in: PubMed
    Score: 0,017
  37. ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Nat Immunol. 2023 07; 24(7):1161-1172.
    View in: PubMed
    Score: 0,016
  38. Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet HIV. 2023 06; 10(6):e363-e374.
    View in: PubMed
    Score: 0,016
  39. Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005). Vaccine. 2023 05 26; 41(23):3486-3492.
    View in: PubMed
    Score: 0,016
  40. Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19. Viruses. 2023 02 06; 15(2).
    View in: PubMed
    Score: 0,016
  41. T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa. AIDS. 2023 01 01; 37(1):105-112.
    View in: PubMed
    Score: 0,016
  42. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial. Lancet Infect Dis. 2023 03; 23(3):295-306.
    View in: PubMed
    Score: 0,016
  43. Acceptability of Implants for HIV Treatment in Young Children: Perspectives of Health Care Providers in Johannesburg, South Africa. AIDS Patient Care STDS. 2022 10; 36(10):389-395.
    View in: PubMed
    Score: 0,016
  44. Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial. BMC Infect Dis. 2022 Jul 20; 22(1):634.
    View in: PubMed
    Score: 0,015
  45. Approaches to accelerating the study of new antiretrovirals in pregnancy. J Int AIDS Soc. 2022 07; 25 Suppl 2:e25916.
    View in: PubMed
    Score: 0,015
  46. Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial. Lancet HIV. 2022 05; 9(5):e309-e322.
    View in: PubMed
    Score: 0,015
  47. The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir disoproxil fumarate/emtricitabine/efavirenz. AIDS. 2021 12 15; 35(Suppl 2):S117-S125.
    View in: PubMed
    Score: 0,015
  48. Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial. J Antimicrob Chemother. 2021 11 12; 76(12):3237-3246.
    View in: PubMed
    Score: 0,015
  49. Challenges in recruiting children to a multidrug-resistant TB prevention trial. Int J Tuberc Lung Dis. 2021 10 01; 25(10):814-822.
    View in: PubMed
    Score: 0,015
  50. Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial. Clin Trials. 2021 12; 18(6):681-689.
    View in: PubMed
    Score: 0,015
  51. Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial. PLoS One. 2021; 16(8):e0255250.
    View in: PubMed
    Score: 0,014
  52. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV. 2021 09; 8(9):e568-e580.
    View in: PubMed
    Score: 0,014
  53. Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy. Clin Infect Dis. 2021 07 15; 73(2):e312-e320.
    View in: PubMed
    Score: 0,014
  54. Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age. AIDS. 2021 07 15; 35(9):1413-1421.
    View in: PubMed
    Score: 0,014
  55. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 05 20; 384(20):1899-1909.
    View in: PubMed
    Score: 0,014
  56. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021 04 03; 397(10281):1276-1292.
    View in: PubMed
    Score: 0,014
  57. Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding. J Acquir Immune Defic Syndr. 2021 04 01; 86(4):450-454.
    View in: PubMed
    Score: 0,014
  58. Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review. PLoS One. 2021; 16(3):e0248423.
    View in: PubMed
    Score: 0,014
  59. Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):201-204.
    View in: PubMed
    Score: 0,014
  60. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 05 20; 384(20):1885-1898.
    View in: PubMed
    Score: 0,014
  61. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 03 06; 397(10277):881-891.
    View in: PubMed
    Score: 0,014
  62. Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa. AIDS. 2021 02 02; 35(2):205-211.
    View in: PubMed
    Score: 0,014
  63. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
    View in: PubMed
    Score: 0,014
  64. African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus. Clin Infect Dis. 2020 10 23; 71(7):e105-e114.
    View in: PubMed
    Score: 0,014
  65. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. Lancet HIV. 2020 10; 7(10):e666-e676.
    View in: PubMed
    Score: 0,014
  66. Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission. PLoS One. 2020; 15(5):e0233693.
    View in: PubMed
    Score: 0,013
  67. COVID-19 in Africa: care and protection for frontline healthcare workers. Global Health. 2020 05 15; 16(1):46.
    View in: PubMed
    Score: 0,013
  68. Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir. Antimicrob Agents Chemother. 2020 04 21; 64(5).
    View in: PubMed
    Score: 0,013
  69. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2020 07; 20(7):851-863.
    View in: PubMed
    Score: 0,013
  70. Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017. Pediatr Infect Dis J. 2020 02; 39(2):127-133.
    View in: PubMed
    Score: 0,013
  71. The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial. PLoS One. 2020; 15(1):e0228003.
    View in: PubMed
    Score: 0,013
  72. Neurodevelopmental delay: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2019 12 10; 37(52):7623-7641.
    View in: PubMed
    Score: 0,013
  73. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis. AIDS. 2019 12 01; 33(15):2403-2413.
    View in: PubMed
    Score: 0,013
  74. Association between caregiver depression symptoms and child executive functioning. Results from an observational study carried out in four sub-Saharan countries. AIDS Care. 2020 04; 32(4):486-494.
    View in: PubMed
    Score: 0,013
  75. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. N Engl J Med. 2019 08 29; 381(9):803-815.
    View in: PubMed
    Score: 0,013
  76. Why South Africa urgently needs to support the development of pregnancy exposure registries. S Afr Med J. 2019 04 29; 109(5):294-295.
    View in: PubMed
    Score: 0,012
  77. What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. Pediatr Infect Dis J. 2019 04; 38(4):400-405.
    View in: PubMed
    Score: 0,012
  78. Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). Trials. 2018 Dec 20; 19(1):693.
    View in: PubMed
    Score: 0,012
  79. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration. J Int AIDS Soc. 2018 12; 21(12):e25215.
    View in: PubMed
    Score: 0,012
  80. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV Clin Trials. 2018 12; 19(6):209-224.
    View in: PubMed
    Score: 0,012
  81. Lamivudine monotherapy as a holding regimen for HIV-positive children. PLoS One. 2018; 13(10):e0205455.
    View in: PubMed
    Score: 0,012
  82. Building capacity in neurodevelopment assessment of children in sub-Saharan Africa: A quality assurance model to implement standardized neurodevelopment testing. Child Neuropsychol. 2019 05; 25(4):466-481.
    View in: PubMed
    Score: 0,012
  83. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis. PLoS Med. 2018 07; 15(7):e1002591.
    View in: PubMed
    Score: 0,012
  84. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial. AIDS. 2018 01 14; 32(2):189-204.
    View in: PubMed
    Score: 0,011
  85. Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial. PLoS One. 2017; 12(6):e0178075.
    View in: PubMed
    Score: 0,011
  86. The interaction between equipoise and logistics in clinical trials: A case study. Clin Trials. 2017 Jun; 14(3):314-318.
    View in: PubMed
    Score: 0,011
  87. Cutting the cost of South African antiretroviral therapy using newer, safer drugs. S Afr Med J. 2016 Dec 21; 107(1):28-30.
    View in: PubMed
    Score: 0,010
  88. Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial. Clin Infect Dis. 2016 10 15; 63(8):1113-1121.
    View in: PubMed
    Score: 0,010
  89. Views of Medical Doctors Regarding the 2013 WHO Adult HIV Treatment Guidelines Indicate Variable Applicability for Routine Patient Monitoring, for Their Family Members and for Themselves, in South-Africa. PLoS One. 2016; 11(1):e0145911.
    View in: PubMed
    Score: 0,010
  90. Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012. J Acquir Immune Defic Syndr. 2015 Aug 15; 69(5):593-601.
    View in: PubMed
    Score: 0,010
  91. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children. Pediatr Pulmonol. 2016 Feb; 51(2):157-64.
    View in: PubMed
    Score: 0,009
  92. Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa. Pediatr Infect Dis J. 2015 Feb; 34(2):175-9.
    View in: PubMed
    Score: 0,009
  93. Evaluation of parent-child pairs on antiretroviral therapy in separate adult and pediatric clinics. J Int Assoc Provid AIDS Care. 2014 Nov-Dec; 13(6):555-9.
    View in: PubMed
    Score: 0,008
  94. Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa. AIDS. 2013 Mar 13; 27(5):781-5.
    View in: PubMed
    Score: 0,008
  95. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. Glob Health Action. 2013 Jan 24; 6:19248.
    View in: PubMed
    Score: 0,008
  96. Cost and outcomes of paediatric antiretroviral treatment in South Africa. AIDS. 2013 Jan 14; 27(2):243-50.
    View in: PubMed
    Score: 0,008
  97. Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment. PLoS One. 2011 Feb 23; 6(2):e17273.
    View in: PubMed
    Score: 0,007
  98. Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis. Antivir Ther. 2011; 16(3):417-21.
    View in: PubMed
    Score: 0,007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.